United Biopharmaceutical Inc. (4119) Q1 2026 EPS: 0.17 NTD
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
United Biopharmaceutical Inc. (4119) reported Q1 2026 results with EPS of 0.17 NTD, revenue of 376 million NTD, and net profit of 20 million NTD in the biotechnology and healthcare industry.